. . . . . . . . . . . . . . . . . . . . "TextLocation" . "Results" . "a(SCHEM:Gefitinib) -| complex(p(HGNC:ERBB3),p(PFH:\"PIK3R Class IA Family\"))" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "1.6" . "As shown in Fig. 3C, phosphorylated Akt levels are dramatically reduced by 0.25 μM\ngefitinib. At this concentration, we also observe a reduction in the amount of\nErbB-3 associated with p85 and decreased levels of phosphorylated ErbB-3 and phosphorylated\nEGFR. In contrast, phosphorylated ErbB-2 levels are not significantly\nreduced until concentrations of 4 μM are used." . . "support@belframework.org" . "Selventa" . . . . "2014-07-03T14:29:34.067+02:00"^^ . . .